التفاصيل البيبلوغرافية
| العنوان: |
Mechanistic study of lipid metabolism disorders in diabetic kidney disease treated with GLQMP based on network pharmacology, molecular docking and in vitro experiments. |
| المؤلفون: |
Shu-Man Liu, Zi-Jie Yan, Man Xiao, Yi-Qiang Xie |
| المصدر: |
Traditional Medicine Research; Feb2024, Vol. 9 Issue 2, p1-10, 10p |
| مصطلحات موضوعية: |
DIABETIC nephropathies, LIPID metabolism disorders, MOLECULAR docking, PHARMACOLOGY, MENDEL'S law |
| مستخلص: |
Background: In this study, we used network pharmacology and molecular docking combined with vitro experiments to explore the potential mechanism of action of Gualou Qumai pill (GLQMP) against DKD. Methods: We screened effective compounds and drug targets using Chinese medicine systemic pharmacology database and analysis platform and Chinese medicine molecular mechanism bioinformatics analysis tools; and searched for DKD targets using human online Mendelian genetics and gene cards. The potential targets of GLQMP for DKD were obtained through the intersection of drug targets and disease targets. Cytoscape software was applied to build herbal medicine-active compound-target-disease networks and analyze them; protein-protein interaction networks were analyzed using the STRING database platform; gene ontology and Kyoto Encyclopedia of Genes and Genomes were used for gene ontology and gene and genome encyclopedia to enrich potential targets using the DAVID database; and the AutoDock Vina 1.1.2 software for molecular docking of key targets with corresponding key components. In vitro experiments were validated by CCK8, oil red O staining, TC, TG, RT-qPCR, and Western blot. Results: Through network pharmacology analysis, a total of 99 potential therapeutic targets of GLQMP for DKD and the corresponding 38 active compounds were obtained, and 5 core compounds were identified. By constructing the protein-protein interaction network and performing network topology analysis, we found that PPARA and PPARG were the key targets, and then we molecularly docked these two key targets with the 38 active compounds, especially the 5 core compounds, and found that PPARA and PPARG had good binding ability with a variety of compounds. In vitro experiments showed that GLQMP was able to ameliorate HK-2 cell injury under high glucose stress, improve cell viability, reduce TC and TG levels as well as decrease the accumulation of lipid droplets, and RT-qPCR and Western blot confirmed that GLQMP was able to promote the expression levels of PPARA and PPARG. Conclusion: Overall, this study revealed the active compounds, important targets and possible mechanisms of GLQMP treatment for DKD, and conducted preliminary verification experiments on its correctness, provided novel insights into the treatment of DKD by GLQMP. [ABSTRACT FROM AUTHOR] |
|
Copyright of Traditional Medicine Research is the property of TMR Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder